[go: up one dir, main page]

MXPA05008138A - Composiciones orales de fenretinida que tienen biodisponibilidad incrementada y metodos de uso de las mismas. - Google Patents

Composiciones orales de fenretinida que tienen biodisponibilidad incrementada y metodos de uso de las mismas.

Info

Publication number
MXPA05008138A
MXPA05008138A MXPA05008138A MXPA05008138A MXPA05008138A MX PA05008138 A MXPA05008138 A MX PA05008138A MX PA05008138 A MXPA05008138 A MX PA05008138A MX PA05008138 A MXPA05008138 A MX PA05008138A MX PA05008138 A MXPA05008138 A MX PA05008138A
Authority
MX
Mexico
Prior art keywords
fenretinide
methods
same
oral compositions
increased bioavailability
Prior art date
Application number
MXPA05008138A
Other languages
English (en)
Inventor
Walter A Shaw
Original Assignee
Los Angeles Childrens Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Los Angeles Childrens Hospital filed Critical Los Angeles Childrens Hospital
Publication of MXPA05008138A publication Critical patent/MXPA05008138A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1664—Compounds of unknown constitution, e.g. material from plants or animals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Confectionery (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Seeds, Soups, And Other Foods (AREA)

Abstract

La presente invencion provee una composicion comestible para el suministro oral de una agente activo tal como retinida; la composicion comprende, en la forma de un polvo fluido seco: (a) un agente activo tal como una retinida; (b) composicion de matriz lipidica; (c) opcionalmente un edulcorante; (d) harina; las composicion de la invencion se pueden administrar per se o mezclar con un portador alimenticio solido o liquido, para el consumo directo oral a traves de un sujeto o la administracion a traves de un tubo de alimentacion.
MXPA05008138A 2003-01-31 2004-01-29 Composiciones orales de fenretinida que tienen biodisponibilidad incrementada y metodos de uso de las mismas. MXPA05008138A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44453003P 2003-01-31 2003-01-31
PCT/US2004/003562 WO2004069203A2 (en) 2003-01-31 2004-01-29 Oral compositions of fenretinide having increased bioavailability and methods of using the same

Publications (1)

Publication Number Publication Date
MXPA05008138A true MXPA05008138A (es) 2006-02-17

Family

ID=32850878

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA05008138A MXPA05008138A (es) 2003-01-31 2004-01-29 Composiciones orales de fenretinida que tienen biodisponibilidad incrementada y metodos de uso de las mismas.

Country Status (9)

Country Link
US (3) US7785621B2 (es)
EP (1) EP1594544B1 (es)
JP (1) JP2006518384A (es)
CA (1) CA2513260C (es)
DK (1) DK1594544T3 (es)
ES (1) ES2581184T3 (es)
MX (1) MXPA05008138A (es)
PT (1) PT1594544T (es)
WO (1) WO2004069203A2 (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2569691C (en) 2004-06-23 2010-08-17 Sirion Therapeutics, Inc. Methods and compositions for treating ophthalmic conditions with retinyl derivatives
WO2006052860A2 (en) 2004-11-04 2006-05-18 Sirion Therapeutics, Inc. Modulators of retinol-retinol binding protein (rbp)-transthyretin (ttr) complex formation
EP1688049A1 (de) * 2005-02-03 2006-08-09 findusFit Sportdiätetika GmbH Diätetisches Lebensmittel
CA2667091C (en) * 2005-12-13 2014-06-10 Mcgill University Method for correcting a lipid imbalance in a subject
NZ572601A (en) 2006-03-29 2012-03-30 Univ Wayne State Liposomal nanoparticles and other formulations of fenretinide for use in therapy and drug delivery
WO2009033732A2 (en) * 2007-09-11 2009-03-19 Mondobiotech Laboratories Ag Use of the peptide phpfhlfvy (renin inhibitor) as a therapeutic agent
EP2244702B1 (en) 2008-02-21 2014-09-17 The Royal Institution for the Advancement of Learning/McGill University Treatment of neural diseases or conditions
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
JP2012506912A (ja) 2008-11-04 2012-03-22 ユニバーシティ オブ ケンタッキー リサーチ ファウンデーション アテローム硬化症、メタボリックシンドロームおよびそれらの症状を予防および処置するためのｄ−タガトースベースの組成物および方法
US9510614B2 (en) 2008-11-04 2016-12-06 The Quaker Oats Company Food products prepared with soluble whole grain oat flour
US10689678B2 (en) 2008-11-04 2020-06-23 The Quaker Oats Company Method and composition comprising hydrolyzed starch
US9504272B2 (en) 2008-11-04 2016-11-29 The Quaker Oats Company Method of processing oats to achieve oats with an increased avenanthramide content
US10980244B2 (en) 2008-11-04 2021-04-20 The Quaker Oats Company Whole grain composition comprising hydrolyzed starch
US9622500B2 (en) 2008-11-04 2017-04-18 The Quaker Oats Company Food products prepared with soluble whole grain oat flour
WO2011059776A2 (en) * 2009-10-28 2011-05-19 Revision Therapeutics, Inc Prophylaxis of skin cancer with retinamides
CA2817957C (en) * 2010-11-15 2016-05-10 Texas Tech University Substance for increasing the production of a specific acyl-chain dihydroceramide(s) for improving the effectiveness of cancer treatments
JP2014500258A (ja) 2010-11-15 2014-01-09 ジ・オハイオ・ステイト・ユニバーシティ・リサーチ・ファウンデイション 制御放出粘膜付着システム
WO2012092087A1 (en) 2010-12-29 2012-07-05 Abbott Laboratories Methods for decreasing the incidence of necrotizing enterocolitis, colic, and short bowel syndrome in an infant, toddler, or child
WO2012128881A1 (en) 2011-03-21 2012-09-27 Pepsico, Inc. Method for preparing high acid rtd whole grain beverages
BR112014002956A8 (pt) 2011-07-12 2022-09-06 Pepsico Inc Método de preparar uma bebida láctea contendo aveia
US20130295227A1 (en) * 2012-05-01 2013-11-07 Robbert H. ter Haar Composition Comprising a Sensitive Ingredient
US10057726B2 (en) * 2012-10-02 2018-08-21 Razer (Asia-Pacific) Pte. Ltd. Managing user data on an electronic device
US20150283083A1 (en) * 2012-11-19 2015-10-08 Azanta A/S Dispersible Tablet
CA2966517C (en) 2014-07-25 2021-03-16 Laurent Pharmaceuticals Solid oral formulation of fenretinide
US11172695B2 (en) 2016-03-22 2021-11-16 The Quaker Oats Company Method, apparatus, and product providing hydrolyzed starch and fiber
US20170275662A1 (en) 2016-03-22 2017-09-28 The Quaker Oats Company Method and Apparatus for Controlled Hydrolysis

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI783405A7 (fi) * 1977-12-22 1979-06-23 Stamag Huvudsakligen av kli bestaoende bakverk och foerfarande foer dess framstaellning
DE3119383A1 (de) * 1981-05-15 1982-12-02 Basf Ag, 6700 Ludwigshafen Verfahren zur herstellung von feinverteilten, pulverfoermigen carotinodpraeparaten
JPS59137410A (ja) * 1983-01-27 1984-08-07 Riken Vitamin Co Ltd 安定な粉末ビタミンａの製造法
US4665098A (en) * 1985-03-28 1987-05-12 Mcneilab, Inc. Pharmaceutical composition of N-(4-hydroxyphenyl) retinamide having increased bioavailability
US4874795A (en) * 1985-04-02 1989-10-17 Yesair David W Composition for delivery of orally administered drugs and other substances
IE59067B1 (en) * 1985-04-02 1993-12-15 Yesair David W Composition for delivery of orally administered drugs and other substances
US5002779A (en) * 1989-11-07 1991-03-26 The Procter & Gamble Company Dry stable chocolate beverage containing iron and vitamin C
CA2089003C (en) * 1990-08-13 2001-03-20 David W. Yesair Mixed lipid-bicarbonate colloidal particles for delivering drugs or calories
US5891466A (en) * 1990-08-13 1999-04-06 Yesair; David W. Mixed Liped-Bicarbonate colloidal particles for delivering drugs or calories
CA2102210C (en) * 1991-05-06 1998-08-04 Mark Benson Andon Combined calcium and vitamin d supplements
US6159503A (en) 1993-12-02 2000-12-12 Hercules Incorporated Pectin process and composition
JPH0867666A (ja) * 1994-08-29 1996-03-12 Lion Corp カロチノイド含有粉末製剤及びその製造方法
IL122434A (en) * 1995-06-06 2003-07-06 Biomolecular Products Inc Compositions of mixed colloidal particles in an aqueous environment for sustained delivery of bioactive agents and pharmaceutical preparations therewith
CA2309321A1 (en) 1997-11-10 1999-05-20 G.D. Searle & Co. Use of alkylated iminosugars to treat multidrug resistance
US6254853B1 (en) 1998-05-08 2001-07-03 Vyrex Corporation Water soluble pro-drugs of propofol
CN100358529C (zh) * 1998-06-29 2008-01-02 洛杉矶儿童医院 全反式视黄酰胺和神经酰胺降解抑制剂的制药用途
US6368831B1 (en) 1998-06-29 2002-04-09 Childrens Hospital Los Angeles Treatment of hyperproliferative disorders
US6426069B1 (en) * 1998-09-08 2002-07-30 Biomolecular Products, Inc. Method and compositions for increasing intestinal absorption of fats
EP1117306A2 (en) * 1998-09-29 2001-07-25 The Procter & Gamble Company Low acid beverages supplemented with nutritional calcium sources
JP2001103930A (ja) * 1999-10-08 2001-04-17 Kikkoman Corp イソフラボン化合物強化食品
WO2002032413A2 (en) * 2000-10-17 2002-04-25 Board Of Regents, The University Of Texas System A method to incorporate n-(4-hydroxyphenyl) retinamide in liposomes
JP4384409B2 (ja) 2000-12-05 2009-12-16 チルドレンズ・ホスピタル・ロス・アンジエルス バイオアベイラビリティが増加したフェンレチニドの医薬組成物、およびその使用方法
AU2002235175A1 (en) 2000-12-06 2002-06-18 Tularik, Inc. Lometrexol combination therapy
CA2974803C (en) 2001-10-11 2020-06-02 Biomolecular Products, Inc. Drug delivery composition comprising a lipid matrix

Also Published As

Publication number Publication date
WO2004069203A2 (en) 2004-08-19
ES2581184T3 (es) 2016-09-01
EP1594544B1 (en) 2016-04-06
US20050106216A1 (en) 2005-05-19
JP2006518384A (ja) 2006-08-10
US7780978B2 (en) 2010-08-24
US7785621B2 (en) 2010-08-31
WO2004069203A3 (en) 2005-02-03
DK1594544T3 (en) 2016-07-25
EP1594544A4 (en) 2010-05-26
CA2513260C (en) 2013-01-08
CA2513260A1 (en) 2004-08-19
EP1594544A2 (en) 2005-11-16
US20060008508A1 (en) 2006-01-12
PT1594544T (pt) 2016-07-14
US20050271707A1 (en) 2005-12-08

Similar Documents

Publication Publication Date Title
MXPA05008138A (es) Composiciones orales de fenretinida que tienen biodisponibilidad incrementada y metodos de uso de las mismas.
IL165601A0 (en) Oral pharmaceutical forms of liquid drugs having improved bioavailability
MXPA05012191A (es) Formulaciones con proteinas liquidas estabilizadas en recipientes farmaceuticos.
WO2004054542A3 (en) Oral drug delivery system comprising high viscosity liquid carrier materials
EA200600479A1 (ru) Фармацевтический состав, включающий соединения лантана
WO2007044693A3 (en) Multi-functional ionic liquid compositions
TW200621317A (en) Pharmaceutical composition
MXPA03007857A (es) Compuestos y composiciones para entregar agentes activos.
IL179718A0 (en) Pharmaceutical composition containing irbesartan
IL154318A0 (en) Pharmaceutical compositions for the treatment of movement disorders
EP1993567A4 (en) PER OS ADMINISTRABLE GALLIUM PREPARATIONS AND METHODS OF USE
MX2010004556A (es) Formulacion farmaceutica de acido clavulanico.
PL373456A1 (en) Pharmaceutical preparations for oral administration, containing ion-exchange resins loaded with active ingredients and intrinsically viscous gelling agents as thickening agents
GB2443793B (en) Product, method of manufacture and use
UA92011C2 (ru) Облатка, содержащая стероидные гормоны
WO2007120838A3 (en) Rapidly disintegrating solid oral dosage form of liquid dispersions
TR200101928T2 (tr) Geliştirilmiş kararlılığa sahip bileşimler
MXPA04004907A (es) Composiciones de acetaminofen.
SI1558219T1 (sl) Farmacevtska formulacija olanzapina
TW200503785A (en) Dosage form containing (S)-pantoprazole as active ingredient
AU2003296602A1 (en) Quaternary compounds comprising propolis as the active substance
AU2003224107A1 (en) Soluble composition containing sporopollenin and the use thereof
AU2001289762A1 (en) Pharmaceutical extemporary compositions
WO2003013441A3 (en) Levothyroxine compositions and methods
MX2008001532A (es) Composicion farmaceutica que contiene indometacina y/o acemetacina.

Legal Events

Date Code Title Description
FG Grant or registration